Company Overview of Sonexa Therapeutics, Inc.
Sonexa Therapeutics, Inc. develops therapeutics drugs for the treatment of Alzheimer's disease and related disorders. The company develops ST101, a small and orally active molecule compound that penetrates the blood-brain-barrier. The company was incorporated in 2007 and is based in San Diego, California.
12555 High Bluff Drive
San Diego, CA 92130
Founded in 2007
Key Executives for Sonexa Therapeutics, Inc.
Similar Private Companies By Industry
|SynChem, Inc.||United States|
|BN ImmunoTherapeutics Inc.||United States|
|Abraxis Oncology, Inc.||United States|
|PetLife Organic, Inc.||United States|
|BlueKiwi Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Sonexa Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.